What does SLU-PP-332 actually do inside the body?

It activates three proteins called ERRα, ERRβ, and ERRγ — receptors that normally switch on during aerobic exercise. When activated, they tell cells to burn more fat, build more mitochondria, and boost endurance-related muscle fibers. Animal studies confirm these effects in mice, but human data does not yet exist.[2]

Has SLU-PP-332 been tested in humans?

Not in published clinical trials. All evidence so far comes from mouse models and cell-culture experiments. While the animal results are promising for conditions like obesity and heart failure, the leap from mouse to human is significant, and safety and efficacy in people remain unknown.[1][3]

Why are anti-doping agencies interested in SLU-PP-332?

Because the compound mimics the endurance-boosting effects of aerobic exercise at a molecular level, scientists worry it could be misused in competitive sports. Anti-doping labs are mapping its metabolites — the breakdown products left in the body — so they can develop urine tests to catch any illicit use.[4][6]

Is SLU-PP-332 the same as a steroid or a SARM?

No. Steroids and SARMs target androgen or estrogen receptors. SLU-PP-332 targets estrogen-related receptors, which are structurally different and primarily regulate energy metabolism rather than muscle-building hormonal pathways. It is best classified as a metabolic nuclear receptor agonist, not an anabolic compound.[2]

SLU-PP-332 Exercise Mimetic: What Research Shows

What Is SLU-PP-332?

SLU-PP-332 is a synthetic small molecule — essentially a lab-built chemical tool. It was developed at Saint Louis University, which is where the "SLU" in the name comes from. Its job is to activate a family of proteins inside your cells called estrogen-related receptors, or ERRs. Don't let the word "estrogen" throw you — these receptors have nothing to do with the hormone estrogen. They are master switches for energy metabolism, especially in muscle and heart tissue.

There are three types: ERRα (alpha), ERRβ (beta), and ERRγ (gamma). SLU-PP-332 hits all three, so scientists call it a pan-ERR agonist. An "agonist" is simply something that turns a receptor on. Because these same receptors light up during real aerobic exercise, SLU-PP-332 has earned the nickname exercise mimetic — a molecule that mimics exercise at the molecular level.^[2]

Why Are Scientists Interested in It?

Exercise is genuinely one of the best medicines we have. It cuts the risk of heart disease, diabetes, and early death. But millions of people — the elderly, those with serious illness, or people with mobility issues — simply cannot exercise enough. A safe pharmacological stand-in could be life-changing. That's the big-picture dream driving research into compounds like SLU-PP-332.

What Does the Evidence Show?

Endurance and Muscle Fibers

In the original landmark study, mice given SLU-PP-332 showed a measurable boost in exercise endurance. The compound increased the proportion of type IIa oxidative muscle fibers — the slow-burn fibers elite endurance athletes have more of. It also ramped up mitochondrial function and cellular respiration in muscle cells.^[2] Think of mitochondria as the tiny power plants inside your cells; more efficient power plants mean more stamina.

Obesity and Metabolic Syndrome

Metabolic syndrome is a cluster of problems — excess belly fat, high blood sugar, high blood pressure — that dramatically raises the risk of diabetes and heart disease. In diet-induced obese mice and genetically obese mice, SLU-PP-332 increased energy expenditure and fat burning. Fat mass dropped, and insulin sensitivity improved.^[1] In plain terms: the mice got better at processing energy, similar to what regular cardio does in humans.

Heart Failure

Perhaps the most striking findings come from heart research. A failing heart often loses the ability to burn fatty acids efficiently — it essentially runs out of fuel. When researchers used a pressure-overload model to simulate heart failure in mice, SLU-PP-332 (and a related compound, SLU-PP-915) significantly improved ejection fraction — the percentage of blood the heart pumps out with each beat — and reduced scarring of heart tissue. Survival rates also improved.^[3] The researchers concluded that ERR agonists help the heart maintain its metabolic engine even under severe stress.

Next-Generation Versions

Scientists are already building on SLU-PP-332 by tweaking its chemical structure to create more potent or selective versions. This kind of chemical optimization helps researchers understand exactly which parts of the ERR signaling system are responsible for which effects.^[5]

What About Doping?

Because SLU-PP-332 could theoretically enhance athletic endurance, anti-doping laboratories are paying close attention. Researchers in Cologne have mapped out the compound's metabolites — the breakdown products your body makes after processing a substance — to build tests that could detect its use in athletes.^[4]^[6] This work is still in the in-vitro (lab dish) stage, meaning it used human liver cells rather than actual human subjects.

Important Limits of the Research

Here's the crucial caveat: every study to date has been in animals or cell cultures. No human clinical trials have been published. Animal results do not always translate to people. SLU-PP-332 is a research compound only — it is not approved, prescribed, or validated for human use. Researchers are still figuring out its long-term safety profile, optimal dosing, and how its metabolites behave in the human body.

Curious About Dosing Data From the Literature?

If you want to dig into the doses used in published animal studies, our SLU-PP-332 dosage chart compiles that research data in one place. You can also use the calculator to convert between the weight-based doses reported in mouse studies — a common step researchers use when reviewing preclinical literature. Remember, this is for educational reference only, not a guide for human use.

Sources

A Synthetic ERR Agonist Alleviates Metabolic Syndrome. — The Journal of pharmacology and experimental therapeutics, 2024. PMID 37739806.
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. — ACS chemical biology, 2023. PMID 36988910.
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. — Circulation, 2024. PMID 37961903.
In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential. — Rapid communications in mass spectrometry : RCM, 2026. PMID 41588687.
Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling. — International journal of biological macromolecules, 2026. PMID 41850449.
Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes. — Drug testing and analysis, 2026. PMID 41688415.

SLU-PP-332: The 'Exercise Pill' Researchers Are Watching